XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
  Cornea
  Cataract
  Retina
   ARMD
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

ARMD Channel
subscribe to ARMD newsletter

Latest Research : Ophthalmology : Retina : ARMD

   DISCUSS   |   EMAIL   |   PRINT
Gene for age-related macular degeneration discovered
Mar 10, 2005 - 2:26:00 AM, Reviewed by: Dr.

"This is the first study to identify a common variant of the specific gene being associated with AMD. Caucasian AMD patients are at least four times more likely to have one particular alteration in the CFH gene that produces a different form of the CFH protein compared to individuals without the disease."

 
Researchers at Yale School of Medicine have identified a gene for age-related macular degeneration (AMD) on a region of chromosome 1, leading the way for targeted treatment for this widespread eye disease that causes blindness in millions of people.

The study, led by Josephine Hoh, assistant professor in the Department of Epidemiology and Public Health (EPH) at Yale School of Medicine, will be published online in the March 10 issue of Science Express. Hoh and colleagues from Yale, Rockefeller University and the National Eye Institute, used a highly interdisciplinary approach to conclude that the gene for a substance known as complement factor H (CFH) on chromosome 1 is associated with AMD.

"This is the first study to identify a common variant of the specific gene being associated with AMD," said Hoh. "Caucasian AMD patients are at least four times more likely to have one particular alteration in the CFH gene that produces a different form of the CFH protein compared to individuals without the disease."

AMD is a debilitating eye disease affecting about 15 million people in the United States. It destroys vision by attacking an area of the retina called the macula, particularly in people age 60 or older. The macula is the most sensitive region of the retina, enabling fine-detail vision, reading, driving and leisure tasks such as playing sports and watching movies and television. As part of the normal aging process, yellowish waste deposits called drusen accumulate around the macula, but in individuals with AMD, the drusen are larger and more numerous, killing cells necessary for the nourishment of adjacent retinal photoreceptor cells. As these photoreceptors die in and around the macula, central vision is lost. Peripheral vision is not impaired by AMD.

There are two forms of AMD, the more common "dry" form and the less common "wet" form. The wet form can rapidly lead to blindness, while the dry form progresses more slowly. Both are associated with the same variant in the CFH gene.

Hoh and her team used new genetic analysis and microscopic imaging technologies to find the genetic variant of the AMD gene. "What sets our study apart from previous research is that we used many more genetic markers to find the specific gene and variation," said Hoh. "Past research has involved collecting family data that pinpoint a region on chromosome 1, but failed to find the specific gene. We analyzed the DNA of unrelated patients with AMD and compared their genetic profile to that of AMD-free controls. In this sea of DNA information, we applied computation-intensive, statistical analyses and were able to find the differences between the two groups. Subsequently, the gene association has been confirmed by at least three independent studies with results pending publication."

"This work is not only important for the gene we have found, but also highlights the value in new paradigms for whole genome analysis for chronic diseases," Hoh added. "I believe that in order to find genes responsible for diseases, you have to use a totally different approach, instead of an educated guess. Our findings support greater use of this technique."
 

- Science, Online Publication March 10, 2005.
 

www.yale.edu

 
Subscribe to ARMD Newsletter
E-mail Address:

 

Other authors on the study are Caroline Zeiss, Susan T. Mayne, Michael B. Bracken, Colin Barnstable and Shrikant M. Mane of Yale; Robert J. Klein, Richard S. Sackler, M.D., Chad Haynes and Jurg Ott of Rockefeller University; and Alice K. Henning, John Paul San Giovanni, Emily Y. Chew, M.D., and Frederick L. Ferris, M.D. of the National Eye Institute.

The research was supported by a grant from the Raymond and Beverly Sackler Fund for the Arts and Sciences.


Related ARMD News

Yellow plant pigments lutein and zeaxanthin reduce risk of age-related macular degeneration
Hormone Therapy Does Not Affect Age-Related Vision Loss
Eating Fish Protects Against Macular Degeneration
Research Highlights Risk Factors For Age-Related Vision Loss
FDA approves ranibizumab for the treatment of wet age-related macular degeneration
High Body Mass Index Increase the Genetic Risk of AMD
Ranibizumab Approved for Wet Age-Related Macular Degeneration
New genetic discovery explains 74 percent cases of age-related macular degeneration
Just two genes, Factor H and Factor B, cause blindness in millions
Antioxidants reduce risk of age-related macular degeneration


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us